Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome
Open Access
- 15 January 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 147 (3) , 497-503
- https://doi.org/10.1111/j.1365-2249.2006.03311.x
Abstract
Toll-like receptors (TLR) play an essential role in the activation of both innate and adaptive immune responses. Salivary gland epithelial cells (SGEC) may participate in the development of glandular inflammatory reactions that characterize primary Sjögren's syndrome (pSS). In this study we sought to assess the expression and function of several TLR molecules in cultured non-neoplastic SGEC obtained from pSS patients and disease controls. Long-term cultured non-neoplastic SGEC derived from pSS patients (SS-SGEC) and disease controls (control-SGEC), as well as the monocytic cell line THP-1 (positive control cell line), were examined by reverse transcription–polymerase chain reaction (RT–PCR) analysis and quantitative real-time PCR for mRNA expression of TLR1, -2, -3 and -4 molecules. TLR function was assessed by the induction of the expression (flow cytometry) of the immunoregulatory molecules CD54/intercellular adhesion molecule-1 (ICAM-1), CD40, CD86/B7·2, major histocompatibility complex (MHC) class I and MHC class II following treatment with the TLR ligands: Staphylococcus aureus peptidoglycan (TLR2), the synthetic dsRNA analogue polyinosinic:cytidylic acid (TLR3) and Escherichia coli lipopolysaccharide (TLR4). SGEC were found to express functional TLR2, -3 and -4 molecules, as attested by dose-dependent up-regulation of surface ICAM-1, CD40 and MHC-I expression (as well as of reciprocal TLR mRNA) following treatment with the respective TLR-ligands. SS-SGEC lines displayed significantly higher constitutive expression of TLR1 (P = 0·0027), TLR2 (P = 0·01) and TLR4 (P = 0·03) mRNA compared to control-SGEC. This study demonstrates that cultured SGEC express functional TLR molecules; the high constitutive TLR expression by SS-SGEC is probably suggestive of the intrinsic activation of epithelial cells in pSS and further supports the role of this type of tissue in pathogenesis of the disorder.Keywords
This publication has 39 references indexed in Scilit:
- THE EFFECT OF CIPROFLOXACIN ON CD14 AND TOLL-LIKE RECEPTOR-4 EXPRESSION ON HUMAN MONOCYTESShock, 2006
- The role of epithelial Toll-like receptor expression in host defense and microbial toleranceInnate Immunity, 2005
- The role of epithelial Toll-like receptor expression in host defense and microbial toleranceInnate Immunity, 2005
- Involvement of Toll-like Receptor 3 in the Immune Response of Lung Epithelial Cells to Double-stranded RNA and Influenza A VirusJournal of Biological Chemistry, 2005
- Is targeting Toll‐like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine‐driven inflammation?Immunological Reviews, 2004
- Activation of toll‐like receptor‐9 induces progression of renal disease in MRL‐Fas(lpr) miceThe FASEB Journal, 2004
- Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expressionInternational Journal of Colorectal Disease, 2003
- Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus GroupAnnals of the Rheumatic Diseases, 2002
- Establishment of a convenient system for the long‐term culture and study of non‐neoplastic human salivary gland epithelial cellsEuropean Journal of Oral Sciences, 2002
- Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoproteinEuropean Journal of Immunology, 2001